Placing the universal power of biosensors into the hands of those who need it.
Blood Glucose Testing systems • Blood Coagulation Testing systems • Diagnostic test systems • Point-of-care diagnostics • Electrochemical sensors
51 - 200
💰 $985.1k Post-IPO Debt on 2014-01
March 21
51 - 200